452 related articles for article (PubMed ID: 22067936)
1. Fusobacterium nucleatum: an emerging gut pathogen?
Allen-Vercoe E; Strauss J; Chadee K
Gut Microbes; 2011 Sep; 2(5):294-8. PubMed ID: 22067936
[TBL] [Abstract][Full Text] [Related]
2. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host.
Strauss J; Kaplan GG; Beck PL; Rioux K; Panaccione R; Devinney R; Lynch T; Allen-Vercoe E
Inflamm Bowel Dis; 2011 Sep; 17(9):1971-8. PubMed ID: 21830275
[TBL] [Abstract][Full Text] [Related]
3. Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins.
Zanzoni A; Spinelli L; Braham S; Brun C
Microbiome; 2017 Aug; 5(1):89. PubMed ID: 28793925
[TBL] [Abstract][Full Text] [Related]
4. Myocardial infection due to Fusobacterium nucleatum.
Storm JC; Ford BA; Streit JA
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):373-5. PubMed ID: 24094834
[TBL] [Abstract][Full Text] [Related]
5. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
6. Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha.
Dharmani P; Strauss J; Ambrose C; Allen-Vercoe E; Chadee K
Infect Immun; 2011 Jul; 79(7):2597-607. PubMed ID: 21536792
[TBL] [Abstract][Full Text] [Related]
7. Genetic Manipulation and Virulence Assessment of Fusobacterium nucleatum.
Peluso EA; Scheible M; Ton-That H; Wu C
Curr Protoc Microbiol; 2020 Jun; 57(1):e104. PubMed ID: 32539234
[TBL] [Abstract][Full Text] [Related]
8. The role of coaggregation between Porphyromonas gingivalis and Fusobacterium nucleatum on the host response to mixed infection.
Polak D; Shapira L; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2012 Jul; 39(7):617-25. PubMed ID: 22607053
[TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
[TBL] [Abstract][Full Text] [Related]
10. Myopericarditis associated with Fusobacterium nucleatum-caused liver abscess.
Kearney A; Knoll B
Infect Dis (Lond); 2015 Mar; 47(3):187-9. PubMed ID: 25530149
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium nucleatum: a commensal-turned pathogen.
Han YW
Curr Opin Microbiol; 2015 Feb; 23():141-7. PubMed ID: 25576662
[TBL] [Abstract][Full Text] [Related]
12. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
[TBL] [Abstract][Full Text] [Related]
13. Fusobacterium nucleatum prosthetic hip infection: Case report and review of the literature of unusual anaerobic prosthetic joint infection.
Rodríguez Duque JC; Galindo Rubín P; González Humara B; Quesada Sanz AA; Busta Vallina MB; Fernández-Sampedro M
Anaerobe; 2018 Dec; 54():75-82. PubMed ID: 30118892
[TBL] [Abstract][Full Text] [Related]
14. Acute periprosthetic joint infection due to Fusobacterium nucleatum in a non-immunocompromised patient. Failure using a Debridement, Antibiotics + Implant retention approach.
Corona PS; Lung M; Rodriguez-Pardo D; Pigrau C; Soldado F; Amat C; Carrera L
Anaerobe; 2018 Feb; 49():116-120. PubMed ID: 29307651
[TBL] [Abstract][Full Text] [Related]
15. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
16. The virulence of mixed infection with Streptococcus constellatus and Fusobacterium nucleatum in a murine orofacial infection model.
Kuriyama T; Nakagawa K; Kawashiri S; Yamamoto E; Nakamura S; Karasawa T
Microbes Infect; 2000 Oct; 2(12):1425-30. PubMed ID: 11099928
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum and adverse pregnancy outcomes: Epidemiological and mechanistic evidence.
Vander Haar EL; So J; Gyamfi-Bannerman C; Han YW
Anaerobe; 2018 Apr; 50():55-59. PubMed ID: 29409815
[TBL] [Abstract][Full Text] [Related]
18. Immunological Pathways Triggered by
de Andrade KQ; Almeida-da-Silva CLC; Coutinho-Silva R
Mediators Inflamm; 2019; 2019():7241312. PubMed ID: 31341421
[No Abstract] [Full Text] [Related]
19. Enhanced pathogenicity of Fusobacterium nucleatum adapted to oxidative stress.
Silva VL; Diniz CG; Cara DC; Santos SG; Nicoli JR; Carvalho MA; Farias LM
Microb Pathog; 2005 Oct; 39(4):131-8. PubMed ID: 16125361
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum.
Despins CA; Brown SD; Robinson AV; Mungall AJ; Allen-Vercoe E; Holt RA
mBio; 2021 Oct; 12(5):e0206221. PubMed ID: 34700376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
